rs2736627

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000314.8(PTEN):​c.1026+219C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.911 in 521,718 control chromosomes in the GnomAD database, including 216,918 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.92 ( 64833 hom., cov: 31)
Exomes 𝑓: 0.91 ( 152085 hom. )

Consequence

PTEN
NM_000314.8 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.893

Publications

11 publications found
Variant links:
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
PTEN Gene-Disease associations (from GenCC):
  • Cowden syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • PTEN hamartoma tumor syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • macrocephaly-autism syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • leiomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • activated PI3K-delta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bannayan-Riley-Ruvalcaba syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lhermitte-Duclos disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Proteus-like syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • glioma susceptibility 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-87961337-C-T is Benign according to our data. Variant chr10-87961337-C-T is described in ClinVar as Benign. ClinVar VariationId is 1245322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTENNM_000314.8 linkc.1026+219C>T intron_variant Intron 8 of 8 ENST00000371953.8 NP_000305.3
PTENNM_001304717.5 linkc.1545+219C>T intron_variant Intron 9 of 9 NP_001291646.4 P60484
PTENNM_001304718.2 linkc.435+219C>T intron_variant Intron 8 of 8 NP_001291647.1 P60484

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTENENST00000371953.8 linkc.1026+219C>T intron_variant Intron 8 of 8 1 NM_000314.8 ENSP00000361021.3 P60484-1

Frequencies

GnomAD3 genomes
AF:
0.921
AC:
140132
AN:
152104
Hom.:
64767
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.982
Gnomad AMI
AF:
0.959
Gnomad AMR
AF:
0.906
Gnomad ASJ
AF:
0.837
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.972
Gnomad FIN
AF:
0.930
Gnomad MID
AF:
0.889
Gnomad NFE
AF:
0.881
Gnomad OTH
AF:
0.902
GnomAD4 exome
AF:
0.906
AC:
334811
AN:
369496
Hom.:
152085
Cov.:
4
AF XY:
0.908
AC XY:
177769
AN XY:
195732
show subpopulations
African (AFR)
AF:
0.978
AC:
10607
AN:
10842
American (AMR)
AF:
0.914
AC:
14265
AN:
15606
Ashkenazi Jewish (ASJ)
AF:
0.839
AC:
9415
AN:
11224
East Asian (EAS)
AF:
1.00
AC:
24713
AN:
24716
South Asian (SAS)
AF:
0.968
AC:
38246
AN:
39502
European-Finnish (FIN)
AF:
0.923
AC:
18779
AN:
20340
Middle Eastern (MID)
AF:
0.869
AC:
1388
AN:
1598
European-Non Finnish (NFE)
AF:
0.883
AC:
198227
AN:
224386
Other (OTH)
AF:
0.901
AC:
19171
AN:
21282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1449
2898
4348
5797
7246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
950
1900
2850
3800
4750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.921
AC:
140256
AN:
152222
Hom.:
64833
Cov.:
31
AF XY:
0.924
AC XY:
68755
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.982
AC:
40792
AN:
41546
American (AMR)
AF:
0.907
AC:
13860
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.837
AC:
2906
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5180
AN:
5182
South Asian (SAS)
AF:
0.972
AC:
4689
AN:
4826
European-Finnish (FIN)
AF:
0.930
AC:
9851
AN:
10594
Middle Eastern (MID)
AF:
0.887
AC:
259
AN:
292
European-Non Finnish (NFE)
AF:
0.881
AC:
59936
AN:
68000
Other (OTH)
AF:
0.903
AC:
1908
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
567
1135
1702
2270
2837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.901
Hom.:
7689
Bravo
AF:
0.922
Asia WGS
AF:
0.983
AC:
3418
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
3.0
DANN
Benign
0.68
PhyloP100
0.89
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2736627; hg19: chr10-89721094; API